Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · IEX Real-Time Price · USD

43.76

+2.78 (6.78%)

At close: May 3, 2024, 4:00 PM

42.14

-1.62 (-3.70%)

After-hours: May 3, 2024, 5:30 PM EDT

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	2,632	2,717	1,641	502	1,314	1,009	925	793
Market Cap Growth	-	65.56%	227.08%	-61.83%	30.31%	9.04%	16.66%	-
Enterprise Value	2,357	2,442	1,309	209	1,144	719	672	645
PE Ratio	-14.71	-14.71	-9.06	-7.21	-9.81	-7.17	-12.49	-21.10
PS Ratio	33.99	35.09	69.42	159.06	-	-	-	-
PB Ratio	15.50	16.00	6.21	1.77	7.89	3.59	3.76	5.48
P/FCF Ratio	-19.95	-19.95	-9.45	-10.80	-10.76	-8.00	-14.73	-26.79
P/OCF Ratio	-19.95	-19.95	-9.46	-3.44	-10.77	-8.22	-14.91	-26.91
EV/Sales Ratio	30.44	31.54	55.39	66.28	-	-	-	-
EV/EBITDA Ratio	-14.49	-14.49	-7.51	-3.05	-8.58	-5.14	-9.13	-17.25
EV/EBIT Ratio	-14.34	-14.34	-7.44	-3.00	-8.54	-5.11	-9.08	-17.15
EV/FCF Ratio	-17.93	-17.93	-7.54	-4.50	-9.36	-5.70	-10.71	-21.78
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.01	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-0.04	-0.02	-0.03	-	-
Debt / FCF Ratio	-0.01	-0.01	-0.01	-0.05	-0.03	-0.03	-	-
Quick Ratio	5.27	5.27	8.54	6.82	9.63	11.99	18.59	22.07
Current Ratio	5.58	5.58	8.90	7.10	10.10	12.39	19.05	22.42
Asset Turnover	0.23	0.23	0.07	0.01	0	0	0	0
Interest Coverage	-12.25	-12.25	-33.82	-	-	-	-	-
Return on Equity (ROE)	-96.00%	-96.00%	-74.20%	-20.80%	-63.60%	-67.70%	-31.70%	-67.10%
Return on Assets (ROA)	-55.00%	-55.00%	-54.30%	-18.60%	-58.30%	-60.30%	-30.60%	-45.80%
Return on Capital (ROIC)	-107.80%	-107.80%	-67.30%	-59.32%	-80.52%	-51.30%	-31.84%	-22.39%
Earnings Yield	-7.02%	-6.80%	-11.04%	-13.88%	-10.20%	-13.95%	-8.01%	-4.74%
FCF Yield	-5.18%	-5.01%	-10.59%	-9.26%	-9.30%	-12.51%	-6.79%	-3.73%
Buyback Yield / Dilution	-10.65%	-10.65%	-5.08%	-12.40%	-21.15%	-17.48%	-133.68%	-30.13%
Total Shareholder Return	-10.65%	-10.65%	-5.08%	-12.40%	-21.15%	-17.48%	-133.68%	-30.13%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).